Levobetaxolol HCl

• CAT Number: A000791
• CAS Number: 116209-55-3
• Molecular Formula: C18H29NO3.HCl
• Molecular Weight: 343.89
• Purity: ≥95%
• Synonyms: AL 1577A
• Target: Neuronal Signaling
• Storage: -20°C
• IUPAC Name: (2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride
• InChI: InChI=1S/C18H29NO3.ClH/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16;/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3;1H/t17-;/m0./s1
• InChIKey: CHDPSNLJFOQTRK-LMOVPXPDSA-N
• SMILES: CC(C)NC[C@@H](COC1=CC=C(C=C1)CCOCC2CC2)O.Cl

Levobetaxolol hydrochloride（Cat No.:A000791）is the hydrochloride salt form of levobetaxolol, a selective β₁-adrenergic receptor blocker used primarily in ophthalmology. It is the (S)-enantiomer of betaxolol and is administered as eye drops to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. By selectively inhibiting β₁-receptors in the ciliary body, it decreases aqueous humor production with minimal systemic β₂-related side effects. Levobetaxolol HCl offers a favorable safety profile, including reduced risk of respiratory complications, and is also noted for potential neuroprotective properties in glaucoma management.